Skip to Main Content

Go to Main Navigation


Year Established:
London, , GB
Company Type:
Mid-Sized Business (10-100M TTM Revenue)

Headquartered in Needham, MA, Invicro, a subsidiary of REALM IDx, was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development. Today, Invicro’s multi-disciplinary team provides solutions to pharmaceutical and biotech companies across all stages of the drug development pipeline (Preclinical through Phase 0-IV), all imaging modalities and all therapeutic areas. Invicro’s quantitative biomarker services, pathology solutions, advanced analytics and AI tools, and clinical operational services are backed by Invicro’s industry-leading software informatics platforms, VivoQuant® and iPACS®, as well as their pioneering IQ Analytics Platform, which includes Amyloid-IQ, Tau-IQ and DaT-IQ.

Invicro operates out of nine global laboratories, clinics and sites within the United States in Massachusetts, Michigan, California, Connecticut and globally in the United Kingdom, India, Japan and China.

Learn more by visiting

Site Badges
Invicro LLC
119 Fourth Ave Needham, MA, 02494 United States
Imanova Ltd
Burlington Danes Building London, , W12 0NN United Kingdom
Invicro, Molecular Imaging Center (MIC)
Sanford Consortium for Regenerative Medicine La Jolla, California, 92037 United States
Invicro LLC
115 4th Ave Needham, MA, 02494 United States
1 Enterprise, Suite 1F Aliso Viejo, California, 92656 United States
60 Temple Street New Haven, CT, 06510 United States
Imanova Ltd, Trading as Invicro
Burlington Danes Building London, , W12 0NN United Kingdom

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service